With a market cap of $18.4 billion, Insulet Corporation (PODD) is a global leader in developing innovative insulin delivery ...

CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the company “did not intend to do a full market launch of this product.” ...

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

has announced its donation of several insulin pumps to children with type 1 diabetes who are receiving treatment at the Diabetes Clinic in Salmaniya Medical Complex, part of the government hospitals.

Insulin solutions must be placed in an infusion pump and piggybacked into the lower distal port of a maintenance i.v. line with a rate of at least 20 mL/hr. (Use 0.9% sodium chloride injection if ...

Insulet produces and sells Omnipod, an automated insulin delivery device, which works without the external tubing required by conventional pumps and eliminates the need for multiple daily ...

Dash0 — pronounced “Dash-zero” — is a Datadog competitor whose pitch doesn’t revolve around drastically lowering observability costs. Founder Mirko Novakovic (left in the picture above ...

The rising popularity of the continuous glucose monitor, which is not the same as an insulin pump, has been a huge advance in type 1 diabetes treatment, according to David Maahs, M.D., M.A., Ph.D., ...